Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
EBV-immortalized B lymphocyte cell lines have been widely banked for studying a variety of diseases, including rare genetic disorders. These cell lines represent an important resource for disease modeling with the induced pluripotent stem cell (iPSC) technology. Here we report the generation of iPSCs from EBV-immortalized B-cell lines derived from multiple inherited disease patients via a nonviral method. The reprogramming method for the EBV cell lines involves a distinct protocol compared with that of patient fibroblasts. The B-cell line–derived iPSCs expressed pluripotency markers, retained the inherited mutation and the parental V(D)J rearrangement profile, and differentiated into all 3 germ layer cell types. There was no integration of the reprogramming-related transgenes or the EBV-associated genes in these iPSCs. The ability to reprogram the widely banked patient B-cell lines will offer an unprecedented opportunity to generate human disease models and provide novel drug therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Induced pluripotent stem cells (iPSCs) are useful for studying genetic and rare diseases and can be generated by reprogramming immortalized lymphoblastoid cell lines (LCLs) stored in global repositories with detailed genotype and phenotype data.”
In the citing paper
“Reprogramming efficiency for LCLs has been reported to range from 0.002% to 0.01% when using a transfection efficiency of 60% [2].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
A nonviral minicircle vector for deriving human iPS cells
Jia, F., Wilson, K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., Panetta, N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1426 · Cited by 734
Generation of induced pluripotent stem cells from human blood
Loh, Y.-H., Agarwal, S., Park, I.-H., Urbach, A., Huo, H., Heffner, G. C., Kim, K., Miller, J. D., Ng, K., & Daley, G. Q. (2009) · Blood · doi:10.1182/blood-2009-02-204800 · Cited by 626
Seki, T., Yuasa, S., Oda, M., Egashira, T., Yae, K., Kusumoto, D., Nakata, H., Tohyama, S., Hashimoto, H., Kodaira, M., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.003 · Cited by 584
Mali, P., Chou, B.-K., Yen, J., Ye, Z., Zou, J., Dowey, S., Brodsky, R. A., Ohm, J. E., Yu, W., Baylin, S. B., et al. (2010) · Stem Cells · doi:10.1002/stem.402 · Cited by 417
Self-citation
Research works printed but not linked: 20
- Chun, 2010, Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease., Int J Biol Sci, 6, 796, 10.7150/ijbs.6.796 · DOI
- Woltjen, 2009, piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells., Nature, 458, 766, 10.1038/nature07863 · DOI · Paper page
- Montserrat, 2011, Simple generation of human induced pluripotent stem cells using Poly({beta}-Amino Esters) as non-viral gene delivery system., J Biol Chem, 286, 12417, 10.1074/jbc.M110.168013 · DOI
- Chou, 2011, Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures., Cell Res, 21, 518, 10.1038/cr.2011.12 · DOI · Paper page
- Hu, 2011, Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells., Blood, 117, e109, 10.1182/blood-2010-07-298331 · DOI · Paper page
- Ye, 2009, Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders., Blood, 114, 5473, 10.1182/blood-2009-04-217406 · DOI · Paper page
- Giorgetti, 2009, Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2., Cell Stem Cell, 5, 353, 10.1016/j.stem.2009.09.008 · DOI · Paper page
- Brown, 2010, Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes., PLoS ONE, 5, e11373, 10.1371/journal.pone.0011373 · DOI · Paper page
- Loh, 2010, Reprogramming of T cells from human peripheral blood., Cell Stem Cell, 7, 15, 10.1016/j.stem.2010.06.004 · DOI · Paper page
- Staerk, 2010, Reprogramming of human peripheral blood cells to induced pluripotent stem cells., Cell Stem Cell, 7, 20, 10.1016/j.stem.2010.06.002 · DOI · Paper page
- Pattengale, 1973, Selective transformation of B lymphocytes by E. B. virus., Lancet, 2, 93, 10.1016/S0140-6736(73)93286-8 · DOI
- Worthington, 1994, The Arthritis and Rheumatism Council's National Repository of Family Material: pedigrees from the first 100 rheumatoid arthritis families containing affected sibling pairs., Br J Rheumatol, 33, 970, 10.1093/rheumatology/33.10.970 · DOI
- Beck, 2001, Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies., Cancer Epidemiol Biomarkers Prev, 10, 551
- Amoli, 2008, EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood., Int J Epidemiol, 37, i41, 10.1093/ije/dym285 · DOI · Paper page
- Liu, 2010, Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes., Hepatology, 51, 1810, 10.1002/hep.23626 · DOI · Paper page
- Liu, 2011, In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins., Science Transl Med, 3, 82ra, 10.1126/scitranslmed.3002376 · DOI · Paper page
- Ichida, 2009, A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog., Cell Stem Cell, 5, 491, 10.1016/j.stem.2009.09.012 · DOI · Paper page
- Chen, 1995, A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1., J Virol, 69, 3752, 10.1128/JVI.69.6.3752-3758.1995 · doi:10.1128/jvi.69.6.3752-3758.1995
- Altmann, 2006, Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes., Proc Natl Acad Sci U S A, 103, 14188, 10.1073/pnas.0605985103 · DOI
- Hidvegi, 2010, An autophagy-enhancing drug promotes degradation of mutant AAT Z and reduces hepatic fibrosis., Science, 329, 229, 10.1126/science.1190354 · DOI · Paper page
Cited by
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3577 · Cited by 474
Poleganov, M. A., Eminli, S., Beissert, T., Herz, S., Moon, J.-I., Goldmann, J., Beyer, A., Heck, R., Burkhart, I., Barea Roldan, D., et al. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.045 · Cited by 77
A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction
Bulutoglu, B., Rey-Bedón, C., Mert, S., Tian, L., Jang, Y.-Y., Yarmush, M. L., & Usta, O. B. (2020) · PLOS ONE · doi:10.1371/journal.pone.0229106 · Cited by 41
Self-citationIshii-Teshima, M., Maeda, K., Hanauchi, K., Asechi, E., Setyawan, D., Niki, T., Nakashima, K., Kurita, H., Numano, R., & Shibata, T. (2025) · PLOS One · doi:10.1371/journal.pone.0333491 · Cited by 4
Metadata
- Authors
- Choi, S. M., Liu, H., Chaudhari, P., Kim, Y., Cheng, L., Feng, J., Sharkis, S., Ye, Z., & Jang, Y.-Y.
- Affiliations
- Stem Cell Biology Laboratory, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD;
- Division of Hematology and Stem Cell Program in the Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD; and
- Department of Physiology and Biophysics, State University of New York at Buffalo, Buffalo, NY
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-08-18
- Volume
- 118
- Issue
- 7
- Pages
- 1801-1805
- ISSN
- 0006-4971
- 1528-0020
- Cited by
- 79
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. https://app.cochat.ai/papers/10.1182/blood-2011-03-340620
- The paper
- Choi, S. M., Liu, H., Chaudhari, P., Kim, Y., Cheng, L., Feng, J., Sharkis, S., Ye, Z., & Jang, Y.-Y. (2011). Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells. Blood. https://doi.org/10.1182/blood-2011-03-340620
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.